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Abstract
While only 5% of the human genome is conserved across mammals, a substantially larger portion
is biochemically active, raising the question of whether the additional elements evolve neutrally or
confer a lineage-specific fitness advantage. To address this question, we integrate human variation
information from the 1000 Genomes Project and activity data from the ENCODE Project. A broad
range of transcribed and regulatory non-conserved elements show decreased human diversity,
suggesting lineage-specific purifying selection. Conversely, conserved elements lacking activity
show increased human diversity, suggesting that some recently became non-functional.
Regulatory elements under human constraint in non-conserved regions were found near color
vision and nerve-growth genes, consistent with purifying selection for recently-evolved functions.
Our results suggest continued turnover in regulatory regions, with at least an additional 4% of the
human genome subject to lineage-specific constraint.
Initial sequencing of the human genome revealed that 98.5% of human DNA does not code
for protein (1), raising the question of what fraction of the remaining genome is functional.
Mammalian conservation suggests that ~5% of the human genome (2–3) is conserved due to
non-coding and regulatory roles, but more than 80% is transcribed, bound by a regulator, or
associated with chromatin states suggestive of regulatory functions (4–6). This discrepancy
may result from non-consequential biochemical activity or lineage-specific constraint (7–8).
Similarly, evolutionary turnover in regulatory regions (9–11) may be due to non-
consequential activity in neutrally-evolving regions in each species, or turnover in functional
elements associated with turnover in activity. To resolve these questions, we need new
methods for measuring constraint within a species, rather than between species.
Single nucleotide polymorphisms (SNPs) within human populations have been identified
only every 153 bases per average (12), compared to 4.5 substitutions per site among the
genomes of 29 mammals (2), making it impossible to detect individual constrained elements
(13). Instead, aggregate measures of human diversity across thousands of dispersed elements
are needed. Such measures have been used to show that human constraint correlates with
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mammalian conservation (4, 14–17), mRNA splice sites (18), regulatory elements (19), and
that similar selective pressures act in human and across mammals (2). However, differences
between mammalian and human constraint remain unresolved. Recent positive selection has
been detected by unexpectedly many recent substitutions (20) or extreme patterns of linkage
disequilibrium (LD) and population differentiation (21). However, recent negative selection
has not been investigated, as the paucity of variants segregating in the global population
makes a selective decrease in the diversity of any given locus indistinguishable from a
fortuitous one.
Combining population genomic information from the 1000 Genomes Project (12) and
biochemical data of the ENCODE project (5) we estimated constraint associated with
diverse genomic functions in aggregate over 1567 Mb of `previously-unannotated' regions
encompassing 4.7 million SNPs, excluding exons, proximal promoter regions, and artifact-
prone regions (22) (Fig. 1A). On the basis of SNP density, heterozygosity, and derived allele
frequency (DAF), we developed a statistical procedure for measuring genome-wide
constraint accounting for mutation rate biases and interdependence of allele frequencies due
to LD (22). All P values are derived from this test unless otherwise noted. To distinguish
whether the increased human constraint in active regions (5) could be due solely to
mammalian conservation (Figs. 1B, S1), rather than lineage-specific constraint, we
specifically studied regions not conserved across mammals.
Remarkably, non-conserved active regions showed significant evidence of purifying
selection: SNP density was 10% lower (P<10−64), heterozygosity 13% (P<10−85), and DAF
5% (P<10−65), compared to reductions of 28%, 33%, and 16% respectively for conserved
regions. As non-conserved regions cover a >10-fold larger fraction of the genome, this
suggests that a significant fraction of human constraint lies outside mammalian-conserved
regions. The observed decrease in diversity is not due to undetected conserved regions or the
threshold used to defined conserved elements (Fig. S2), nor to background selection (23)
(Fig. 1C,D), biased gene conversion (Table S1), or decreased mapping to non-reference
alleles (22) (Table S2).
The level of human-specific constraint varies with the observed biochemical activity (Figs.
2, S3–S5, Table S3–S4). Short non-coding RNAs are as strongly constrained as protein-
coding regions. Long non-coding RNAs (lncRNAs) are significantly constrained in human,
even though they lack significant mammalian conservation (5), suggesting primarily
lineage-specific functions. These results are not explained by local mutation rate variation
nor transcription-mediated repair, as DAF is robust to both.
We also found human-specific constraint across non-conserved regulatory features (Fig.
2C,D). Regulatory motifs bound by their regulators show constraint similar to coding
regions, and consistently higher than for non-bound instances (P = 9.5 × 10−7, binomial test)
(Fig. 3). Regulatory regions defined by different assays, including DNase hypersensitivity
and transcription factor binding, show significant and similar levels of human constraint.
Different chromatin states (5, 24) show levels of constraint according to their roles (Fig.
2E,F), with promoter states similar to previously-annotated TSS-proximal regions, enhancer
states significant but weaker, and insulators similar to background regions, consistent with
Ward and Kellis Page 2













enhancer and promoter regions requiring a larger number of motifs than insulator regions. In
contrast, regions that do not overlap with active ENCODE elements and inactive chromatin
states show even lower constraint than ancestral repeats (Fig. 2B,D,F), suggesting they may
provide a more accurate neutral reference than repeats that can have exapted functions (25).
Comparison with primate constraint suggests evolutionary turnover. Mammalian-conserved
regions lacking ENCODE activity show reduced human constraint relative to active regions
(SNP density P<10−41, heterozygosity P<10−52, DAF P<10−14) (Fig. 1B, S1), suggesting
recent loss in function and activity. These also show higher primate divergence relative to
active regions, suggesting some loss of constraint likely predates human-macaque
divergence. Conversely, a fraction of lineage-specific elements likely arose in the common
ancestor of primates, as human-macaque divergence mirrors human diversity for both active
and inactive non-conserved regions (Fig. S6).
To gain insights into the functional adaptations likely involved in this turnover, we applied
our aggregation approach to regulatory regions associated with genes of different functions
(22). We found that highly-constrained non-conserved enhancers are associated with retinal
cone cell development (P<10−4 in GO) and nerve growth (P<10−5 in GO, Reactome, and
KEGG; Fig. S7). This evidence of recent purifying selection for regulation of the nervous
system and color vision is intriguing given their accelerated evolution in primates (20, 26–
27).
We next studied how the number of aggregated regions affects the ability to discriminate
functional elements based on their increased human constraint (Fig. S8). We found no
discriminative power for individual elements, despite a significant global reduction in
heterozygosity (P<10−20, Mann-Whitney-Wilcoxon test on heterozygosity of individual
elements), but discriminative power increased significantly as the sample size grew (22).
We estimated the proportion of the human genome under constraint (PUC) after correcting
for background selection (Fig. S9), and found remarkable agreement between our orthogonal
metrics (Fig. 4A). We estimate that an additional 137 Mb (4%) of the human genome is
under lineage-specific purifying selection (Table S6), consistent with a recent cross-species
extrapolation (28).
Our results suggest that almost half of human constraint lies outside mammalian-conserved
regions, even though the strength of human constraint is higher in conserved elements.
Protein-coding constraint occurs primarily in conserved regions while regulatory constraint
is primarily lineage-specific (Fig. S10), as proposed during mammalian radiation (29).
While differences in activity between mammals (10–11) can be interpreted as lack of
functional constraint (30), our results suggest instead that turnover in activity is
accompanied by turnover in selective constraint. A minority of new regulatory elements lie
in recently-acquired primate specific regions (5) but the bulk lies in mammalian-aligned
regions that provided raw materials for regulatory innovation.
Genome-wide association studies suggest that 85% of disease-associated variants are non-
coding (8), a fraction similar to the proportion of human constraint we estimate lies outside
protein-coding regions (Table S6). This suggests that mutations outside conserved elements
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play important roles in both human evolution and disease, and that large-scale experimental
assays in multiple individuals, cell types and populations can provide a means to their
systematic discovery.
Supplementary Material
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Acknowledgments
We thank the ENCODE Project Consortium data producers and the ENCODE Data Analysis Center for
coordinating access and performing quality control and peak-calling analysis, the Analysis Working Group of the
ENCODE Project Consortium for feedback throughout this project, especially E. Birney, I. Dunham, M. Gerstein,
R. Hardison, J. Stamatoyannopoulos, J. Herrero, S. Parker, P. Sabeti, S. Sunyaev, R. Altshuler, P. Kheradpour, J.
Ernst, and other members of the Kellis lab for discussions. L.W. and M.K. were funded by NIH grants
R01HG004037 and RC1HG005334 and NSF CAREER grant 0644282. Data from the ENCODE consortium is
available from the UCSC Genome Browser at http://genome.ucsc.edu/ENCODE and data from the 1000 Genomes
Project is available at http://www.1000genomes.org/data/. ENCODE annotations, mammalian constraint, human
diversity, background selection, and filtering information for every SNP and every human nucleotide are available
at http://compbio.mit.edu/human-constraint/.
References
1. Lander ES, et al. Nature. Feb 15.2001 409:860. [PubMed: 11237011]
2. Lindblad-Toh K, et al. Nature. Oct 27.2011 478:476. [PubMed: 21993624]
3. Ponting CP, Hardison RC. Genome Res. Nov.2011 21:1769. [PubMed: 21875934]
4. Birney E, et al. Nature. Jun 14.2007 447:799. [PubMed: 17571346]
5. The ENCODE Project Consortium. doi:10.1038/nature11247, (In review)
6. Ernst J, et al. Nature. May 5.2011 473:43. [PubMed: 21441907]
7. Nelson MR, et al. Science. May 17.2012
8. Hindorff LA, et al. Proc Natl Acad Sci U S A. Jun 9.2009 106:9362. [PubMed: 19474294]
9. Lowe CB, et al. Science. Aug 19.2011 333:1019. [PubMed: 21852499]
10. Brawand D, et al. Nature. Oct 20.2011 478:343. [PubMed: 22012392]
11. Schmidt D, et al. Science. May 21.2010 328:1036. [PubMed: 20378774]
12. 1000 Genomes Project Consortium. Nature. Oct 28.2010 467:1061. [PubMed: 20981092]
13. Eddy SR. PLoS Biol. Jan.2005 3:e10. [PubMed: 15660152]
14. Asthana S, et al. Proc Natl Acad Sci U S A. Jul 24.2007 104:12410. [PubMed: 17640883]
15. Drake JA, et al. Nat Genet. Feb.2006 38:223. [PubMed: 16380714]
16. Torgerson DG, et al. PLoS Genet. Aug.2009 5:e1000592. [PubMed: 19662163]
17. Katzman S, et al. Science. Aug 17.2007 317:915. [PubMed: 17702936]
18. Lomelin D, Jorgenson E, Risch N. Genome Res. Mar.2010 20:311. [PubMed: 20032171]
19. Mu XJ, Lu ZJ, Kong Y, Lam HY, Gerstein MB. Nucleic Acids Res. Sep 1.2011 39:7058.
[PubMed: 21596777]
20. Pollard KS, et al. Nature. Sep 14.2006 443:167. [PubMed: 16915236]
21. Sabeti PC, et al. Science. Jun 16.2006 312:1614. [PubMed: 16778047]
22. SOM
23. McVicker G, Gordon D, Davis C, Green P. PLoS Genet. May.2009 5:e1000471. [PubMed:
19424416]
24. Ernst J, Kellis M. Nat Biotechnol. Aug.2010 28:817. [PubMed: 20657582]
25. Bejerano G, et al. Nature. May 4.2006 441:87. [PubMed: 16625209]
26. Dorus S, et al. Cell. Dec 29.2004 119:1027. [PubMed: 15620360]
27. Jacobs GH. Adv Exp Med Biol. 2012; 739:156. [PubMed: 22399401]
Ward and Kellis Page 4













28. Meader S, Ponting CP, Lunter G. Genome Res. Oct.2010 20:1335. [PubMed: 20693480]
29. Mikkelsen TS, et al. Nature. May 10.2007 447:167. [PubMed: 17495919]
30. Li XY, et al. PLoS Biol. Feb.2008 6:e27. [PubMed: 18271625]
31. Quinlan AR, Hall IM. Bioinformatics. Mar 15.2010 26:841. [PubMed: 20110278]
32. Harrow J, et al. Genome Biol. 2006; 7(Suppl 1):S4, 1. [PubMed: 16925838]
33. Karolchik D, et al. Nucleic Acids Res. Jan 1.2004 32:D493. [PubMed: 14681465]
34. Paten B, et al. Genome Res. Nov.2008 18:1829. [PubMed: 18849525]
35. Garber M, et al. Bioinformatics. Jun 15.2009 25:i54. [PubMed: 19478016]
36. Gibbs RA, et al. Science. Apr 13.2007 316:222. [PubMed: 17431167]
37. Gabriel SB, et al. Science. Jun 21.2002 296:2225. [PubMed: 12029063]
38. Hartl, DL.; Clark, AG. Principles of population genetics. ed. 4th. Sinauer Associates; Sunderland,
Mass: 2007. p. xvp. 652
39. Flicek P, et al. Nucleic Acids Res. Nov 28.2011
40. Kanehisa M, Goto S, Sato Y, Furumichi M, Tanabe M. Nucleic Acids Res. Jan.2012 40:D109.
[PubMed: 22080510]
41. Croft D, et al. Nucleic Acids Res. Jan.2011 39:D691. [PubMed: 21067998]
42. Subramanian A, et al. Proc Natl Acad Sci U S A. Oct 25.2005 102:15545. [PubMed: 16199517]
43. Berglund J, Pollard KS, Webster MT. PLoS Biol. Jan 27.2009 7:e26. [PubMed: 19175294]
Ward and Kellis Page 5














(A) Only a small fraction (purple) of biochemically-active regions (red) overlaps conserved
elements (blue). (B) Active regions (red) show reduced heterozygosity relative to inactive
regions outside conserved elements (white), suggesting lineage-specific purifying selection
(black arrow). Conserved elements that lack activity (blue) show increased human
heterozygosity relative to active conserved regions (purple), suggesting recent loss of
selective constraint (white arrow). (C–D) Comparison of mean heterozygosity for
ENCODE-annotated elements (red) vs. non-ENCODE elements (black) and active
chromatin (green) vs. inactive (blue) shows a consistent reduction at varying genetic
distances from exons (C) and varying expected background selection (D), confirming the
heterozygosity reduction is due to purifying selection. Shaded regions represent a 95%
confidence interval on the mean heterozygosity assuming independence between bases.
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Mean frequency of derived alleles (vertical bar) relative to samples of similar size
(distribution) from the specified background for previous annotations (grey), ENCODE
(blue) and chromatin states (red). Sizes of regions are shown.
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Average heterozygosity for bound regulatory motif instances (x-axis) and non-bound
regulatory motif instances (y-axis), evaluated in non-conserved regions of the genome to
estimate lineage-specific constraint. Shown are all transcription factors with at least 30 kb of
bound instances (red points). Numbers in parentheses indicate number of bound and number
of non-bound instances, respectively.
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Estimated proportion of bases under constraint (PUC) in human using SNP density (x-axis)
and DAF (y-axis), across previously-annotated elements (squares) and newly-annotated
ENCODE elements (circles), in both conserved (blue) and non-conserved (black) regions.
Error bars denote 95% confidence intervals on the estimates. Each metric was linearly
scaled between 0% for non-ENCODE non-conserved regions and 100% for conserved non-
degenerate coding positions in each background selection bin separately (Fig. S8)
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